Effects of losartan and candesartan monotherapy and losartan/hydrochlorothiazide combination therapy in patients with mild to moderate hypertension

Authors: Losartan Trial Investigators; Manolis A.J.; Grossman E.; Jelakovic B.; Jacovides A.; Bernhardi D.C.; Cabrera W.J.; Watanabe L.A.; Barragan J.; Matadamas N.; Mendiola A.; Woo K.S.; Zhu J.R.; Mejia A.D.; Bunt T.; Dumortier T.; Smith R.D.¹

Source: Clinical Therapeutics, Volume 22, Number 10, October 2000 , pp. 1186-1203(18)

Publisher: Elsevier

Keywords: angiotensin II antagonist; antihypertensive therapy; losartan; candesartan hydrochlorothiazide

Language: English

Document Type: Research article

DOI: 10.1016/S0149-2918(00)83062-3

Affiliations: 1: nMerck & Co, Inc, , Whitehouse Station, New Jersey, U.S.A.

Links for this article

http://www.ingentaconnect.com/els/01492918/2000/00000022/00000010/art83062
http://openurl.ingenta.com/content?genre=article&issn=0149-2918&volume=22&issue=10&spage=1186&epage=1203
http://dx.doi.org/10.1016/S0149-2918(00)83062-3